Powering assets with AI: unlocking next-level potential

 

Contact Us

Transforming complexity into streamlined clinical readiness

Partnering with BioStrand enables the integration of cutting-edge AI with wet lab precision to optimize and dynamically adapt antibody assets to your specific needs. Enhanced with AI, we can refine existing assets or engineer in silico solutions, aimed at de-risking the development process and optimizing efficacy. Our streamlined approach is designed to accelerate progress from discovery to clinic.

Driven by innovation, acceleration, outcomes

 

Advanced antibody design and AI-powered engineering

Our AI-driven solutions in multi-feature-based epitope-paratope engineering are designed to improve key attributes such as potency, binding affinity, stability, specificity and functionality for clinical readiness while minimizing developability risk. By leveraging computational models and multi-parametric analysis, we optimize and fine-tune antibody properties with a focus on precision, structural profiling, and atomic interaction insights to accelerate development timelines.

See case study

Engineering-3
 

Advanced multi-omics data integration

By integrating genomic, proteomic, and transcriptomic data, analytical data and literature we uncover key relationships and hidden characteristics about target and antibody down to the subsequence level. 

Screenshot 2024-12-12 at 3.34.51 PM

Explore our assets

Discover our fully vetted, AI-optimized antibody programs, developed for partner out-licensing. These assets are engineered for maximum potency and efficacy across multiple indications, from early-stage discovery to IND-enabling programs.

  

See pipeline

Contact us to learn more

Reach out today to explore how our AI-enhanced solutions, paired with wet lab validation, can elevate your biotherapeutic programs and accelerate your path to clinical success.

Contact us